Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors

Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors

2020, VOL. 9 | Huan Han, Qingfeng Ma, Cong Li, Rui Liu, Li Zhao, Wei Wang, Pingan Zhang, Xinghui Liu, Guosheng Gao, Fang Liu, Yingan Jiang, Xiaoming Cheng, Chengliang Zhu, Yuchen Xia
This study investigates the role of cytokine profiles in predicting the severity of COVID-19. Researchers from multiple institutions in China analyzed serum samples from 102 COVID-19 patients and 45 healthy controls. The patients were categorized into moderate, severe, and critical groups based on their symptoms. The results showed that COVID-19 patients had significantly higher levels of inflammatory cytokines (TNF-α, IFN-γ, IL-2, IL-4, IL-6, and IL-10) and C-Reactive Protein (CRP) compared to healthy controls. Within the COVID-19 patients, serum levels of IL-6 and IL-10 were significantly higher in the critical group compared to the moderate and severe groups. IL-10 levels were positively correlated with CRP (r = 0.41, P < 0.01). Univariate logistic regression analysis and receiver operating characteristic (ROC) curve analysis confirmed that IL-6 and IL-10 are predictive markers for disease severity. The study suggests that higher levels of cytokine storm are associated with more severe disease development, and IL-6 and IL-10 can be used as predictors for rapid diagnosis of patients at higher risk of disease deterioration. Given the high levels of cytokines induced by SARS-CoV-2, reducing inflammation-related lung damage is critical in treatment.This study investigates the role of cytokine profiles in predicting the severity of COVID-19. Researchers from multiple institutions in China analyzed serum samples from 102 COVID-19 patients and 45 healthy controls. The patients were categorized into moderate, severe, and critical groups based on their symptoms. The results showed that COVID-19 patients had significantly higher levels of inflammatory cytokines (TNF-α, IFN-γ, IL-2, IL-4, IL-6, and IL-10) and C-Reactive Protein (CRP) compared to healthy controls. Within the COVID-19 patients, serum levels of IL-6 and IL-10 were significantly higher in the critical group compared to the moderate and severe groups. IL-10 levels were positively correlated with CRP (r = 0.41, P < 0.01). Univariate logistic regression analysis and receiver operating characteristic (ROC) curve analysis confirmed that IL-6 and IL-10 are predictive markers for disease severity. The study suggests that higher levels of cytokine storm are associated with more severe disease development, and IL-6 and IL-10 can be used as predictors for rapid diagnosis of patients at higher risk of disease deterioration. Given the high levels of cytokines induced by SARS-CoV-2, reducing inflammation-related lung damage is critical in treatment.
Reach us at info@study.space